Welcome, Guest. Please login or register.
July 24, 2024, 08:03:26 pm

Login with username, password and session length

  • Total Posts: 55130
  • Total Topics: 4851
  • Online Today: 225
  • Online Ever: 1314
  • (June 22, 2016, 05:23:42 am)
Users Online
Users: 0
Guests: 40
Total: 40


Welcome to the Hep Forums, a round-the-clock discussion area for people who have Fatty Liver Disease, Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Australia is Making Progress Toward Eliminating Hep C in People Who Inject Drugs  (Read 7770 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 784
    • Hep Mag
Thanks to a health care system that provides unrestricted access to direct-acting antiviral (DAA) treatment for hepatitis C virus (HCV), Australia is making good progress in eliminating the virus among people who inject drugs (PWID).

As described in Clinical Infectious Diseases, researchers conducted an observational study, called the ETHOS Engage study, of PWID attending drug treatment clinics and needle and syringe programs (NSPs) in Australia. The participants received HCV testing and completed a questionnaire that included self-reported hep C treatment history.

Between May 2018 and September 2019, 1,443 participants were enrolled. Sixty-four percent injected drugs during the last month, and 74% were receiving medication-assisted treatment for opioid use disorder.



© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.